LLY Eli Lilly and Company | US5324571083
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 1.066.549.444.608 | 821.814.512.451,17 | 961.623.712.060,55 | 683.526.683.000 |
| Enterprise Value | 1.104.637.460.480 | 859.902.512.451,17 | 996.858.712.060,55 | 716.241.383.000 |
| Trailing P/E | 42,55 | 32,51 | 46,59 | 48,82 |
| Forward P/E | 26,66 | - | - | - |
| Price to Sales | 14,76 | 11,37 | 14,75 | 14,9 |
| Price to Book | 34,25 | 26,34 | 36,24 | 28,73 |
| EV/Revenue | 15,29 | 11,9 | 15,29 | 15,61 |
| EV/EBITDA | 30,5 | 21,33 | 27,28 | 30,13 |